Replies to post #199781 on Biotech Values

[DewDiligence]

PTLA—How often will an antidote like this be needed? Is there a market for this?

There’s a market for an FXa reversal agent, but I don’t think it’s an especially big market. The companies who promote FXa inhibitors (PFE/BMY, JNJ/Bayer, etc.) are unlikely to emphasize the availability of antidotes in their marketing messages.